SL Therapeutics Inc
258540
Company Profile
Business description
SL Therapeutics Inc formerly, StemLab Inc through its cell reprogramming technology manufactures MRI systems and various routine clinical imaging protocols. The company also develops therapeutic solutions to treat diseases that have no cures. It also develops cells and culture media for rejuvenation to directly address the issue of anti-aging.
Contact
Sector
Healthcare
Stock type
Industry
Medical Devices
Fiscal Year End
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,959.70 | 106.00 | 1.35% |
| CAC 40 | 7,273.12 | 168.32 | 2.37% |
| DAX 40 | 20,954.83 | 580.73 | 2.85% |
| Dow JONES (US) | 40,524.79 | 312.08 | 0.78% |
| FTSE 100 | 8,134.34 | 170.16 | 2.14% |
| HKSE | 21,417.40 | 502.71 | 2.40% |
| NASDAQ | 16,831.48 | 107.03 | 0.64% |
| Nikkei 225 | 33,982.36 | 396.78 | 1.18% |
| NZX 50 Index | 12,107.54 | 88.41 | 0.74% |
| S&P 500 | 5,405.97 | 42.61 | 0.79% |
| S&P/ASX 200 | 7,748.60 | 102.10 | 1.34% |
| SSE Composite Index | 3,262.81 | 24.58 | 0.76% |